BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31981704)

  • 1. Crystallo-co-spray drying as a new approach to manufacturing of drug/excipient agglomerates: Impact of processing on the properties of paracetamol and lactose mixtures.
    McDonagh AF; Tajber L
    Int J Pharm; 2020 Mar; 577():119051. PubMed ID: 31981704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the degree of intimate mixing on the compaction properties of materials produced by crystallo-co-spray drying.
    McDonagh AF; Duff B; Brennan L; Tajber L
    Eur J Pharm Sci; 2020 Nov; 154():105505. PubMed ID: 32777259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose.
    Chidavaenzi OC; Buckton G; Koosha F
    Int J Pharm; 2001 Mar; 216(1-2):43-9. PubMed ID: 11274805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of cocrystals in an excipient matrix by spray drying.
    Walsh D; Serrano DR; Worku ZA; Norris BA; Healy AM
    Int J Pharm; 2018 Jan; 536(1):467-477. PubMed ID: 29241701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Characterization of Multifunctional Directly Compressible Co-processed Excipient by Spray Drying Method.
    Chauhan SI; Nathwani SV; Soniwala MM; Chavda JR
    AAPS PharmSciTech; 2017 May; 18(4):1293-1301. PubMed ID: 27480443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of α-lactose monohydrate as a direct compression excipient using roller compaction.
    Abu Fara D; Rashid I; Alkhamis K; Al-Omari M; Chowdhry BZ; Badwan A
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2038-2047. PubMed ID: 30095020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of acetaminophen as an active pharmaceutical ingredient into porous lactose.
    Ebrahimi A; Saffari M; Dehghani F; Langrish T
    Int J Pharm; 2016 Feb; 499(1-2):217-227. PubMed ID: 26768724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of directly compressible powders via co-spray drying.
    Gonnissen Y; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Aug; 67(1):220-6. PubMed ID: 17317123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on new co-processed excipient consisting of lactose and gelatinized starch].
    Wang ST; Zhang J; Lin X; Shen L; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4329-34. PubMed ID: 25850261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Recrystallization of Amorphous Lactose in Nanocomposites Formed by Spray-Drying.
    Hellrup J; Alderborn G; Mahlin D
    J Pharm Sci; 2015 Nov; 104(11):3760-3769. PubMed ID: 26182904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties.
    Corrigan DO; Healy AM; Corrigan OI
    Int J Pharm; 2002 Mar; 235(1-2):193-205. PubMed ID: 11879754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
    Vilhelmsen T; Eliasen H; Schaefer T
    Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
    Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
    Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2004 Apr; 273(1-2):171-82. PubMed ID: 15010141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spherical agglomerates of lactose with enhanced mechanical properties.
    Lamešić D; Planinšek O; Lavrič Z; Ilić I
    Int J Pharm; 2017 Jan; 516(1-2):247-257. PubMed ID: 27866980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.